Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients

Post time 2022-7-2 13:37:01

journal：International Journal of Cancer

Authors：Min Jin Ha; Akshara Singareeka Raghavendra; Nicole M. Kettner; Wei Qiao; Senthil Damodaran; Rachel M. Layman; Kelly K. Hunt; Yu Shen; Debu Tripathy; Khandan Keyomarsi

Published date：2022-6-15

DOI：10.1002/ijc.33959

Article link：http://dx.doi.org/10.1002/ijc.33959

Article Source：Wiley。

Remark：

Post time 2022-7-2 13:37:02

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-7-2 14:12:13

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today